Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Outline of New Born Baby checking of Neurological Illnesses

Bodensteiner JB

More than 400 different disorders fall under the umbrella of neuromuscular diseases, which are diverse in their phenotypic range. Due to their rarity and complexity, neuromuscular illnesses are frequently only discovered after a very long period of time, at which point irreparable muscle loss may reduce the effectiveness of treatments, when any are available. Neonatal screening may offer an answer for early detection and therapy in this situation. PRISMA standards were followed to perform a systematic evaluation of the literature in PubMed up to May 1, 2021, which included conditions with a clear involvement of the peripheral nervous system and classic neuromuscular illnesses (including central nervous system disease with severe neuropathy). We identified seven disorders for which newborn screening data were available: Krabbe disease, X-linked adrenoleukodystrophy, Pompe disease, Duchenne muscular dystrophy, spinal muscular atrophy, Myotonic dystrophy type, Krabbe disease, X-linked adrenoleuko- dystrophy, Pompe disease and metachromatic leukodystrophy. Changing from a biochemical to a genetic-based approach will require a global technical shift in newborn screening for neuromuscular diseases. In order for innovative medicines to be as effective as possible, the rapid development of therapy also necessitates the ability to quickly adjust the list of ailments treated.